Beta Bionics, Inc. Common Stock Net Asset Momentum
Beta Bionics, Inc. Common Stock net asset momentum. Beta Bionics, Inc. Common Stock (BBNX) recorded a net asset momentum of 278.4% as of December 2025, with net assets of $287.61 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore Beta Bionics, Inc. Common Stock cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Beta Bionics, Inc. Common Stock (2022–2025)
Net asset momentum of Beta Bionics, Inc. Common Stock from 2022 to 2025. This chart tracks Beta Bionics, Inc. Common Stock's year-over-year net asset growth across 4 annual reporting periods from 2022 to 2025. The most recent momentum reading is +278.4%, with net assets of $287.61 Million USD as of December 2025. See Beta Bionics, Inc. Common Stock shareholders equity for net asset value and shareholders' equity analysis.
Beta Bionics, Inc. Common Stock Net Asset Momentum by Year (2022–2025)
Beta Bionics, Inc. Common Stock net asset momentum by year from 2022 to 2025. The table below shows the complete annual net asset history for Beta Bionics, Inc. Common Stock from 2022 to 2025, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see Beta Bionics, Inc. Common Stock (BBNX) total market value.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $287.61 Million | $328.74 Million | $41.13 Million | ▲ +278.4% |
| 2024 | $76.01 Million | $149.65 Million | $73.63 Million | ▲ +29.7% |
| 2023 | $58.61 Million | $110.04 Million | $51.43 Million | ▲ +134.5% |
| 2022 | $-170.03 Million | $35.53 Million | $205.56 Million | — |